IMRT or VMAT

RADIATION2 trials

Sponsors

Tianjin Medical University Cancer Institute and Hospital, West China Hospital

Conditions

Esophageal CancerHead and Neck Neoplasms

Phase 2

A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer

West China HospitalHead and Neck Neoplasms

Start: 2020-06-01End: 2025-05-31Target: 32Updated: 2020-05-28

Unknown Phase

Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC

Tianjin Medical University Cancer Institute and HospitalEsophageal Cancer

Start: 2018-09-17End: 2021-09-01Target: 20Updated: 2019-01-09

Related Papers

Spatial distribution of tumor-infiltrating T cells indicated immune response status under chemoradiotherapy plus PD-1 blockade in esophageal cancer

Frontiers in Immunology2023-05-1914 citations

Spatial Distribution and Predictive Significance of Dendritic Cells and Macrophages in Esophageal Cancer Treated With Combined Chemoradiotherapy and PD-1 Blockade

Frontiers in Immunology2022-01-0336 citations

Addition of camrelizumab to docetaxel, cisplatin, and radiation therapy in patients with locally advanced esophageal squamous cell carcinoma: a phase 1b study

OncoImmunology2021-01-0198 citations